KR20000075181A - Method and probe for detection of Mycobacteria species - Google Patents
Method and probe for detection of Mycobacteria species Download PDFInfo
- Publication number
- KR20000075181A KR20000075181A KR1019990019634A KR19990019634A KR20000075181A KR 20000075181 A KR20000075181 A KR 20000075181A KR 1019990019634 A KR1019990019634 A KR 1019990019634A KR 19990019634 A KR19990019634 A KR 19990019634A KR 20000075181 A KR20000075181 A KR 20000075181A
- Authority
- KR
- South Korea
- Prior art keywords
- mycobacteria
- primers
- probes
- pcr
- mott
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 결핵균을 동정하는 프로브와 프라이머를 개발함으로써 결핵을 조기에 진단하는 방법뿐만 아니라 결핵균의 종류를 밝힘으로써 결핵의 원인균을 정확하게 동정할 수 있는 진단 방법에 관한 것이다.The present invention relates to a method for early diagnosis of tuberculosis by developing probes and primers for identifying tuberculosis bacteria, as well as a diagnostic method that can accurately identify the causative bacteria of tuberculosis by identifying the type of tuberculosis bacteria.
1950년대 비결핵마이코박테리아(Mycobacteria other than tuberculosis, MOTT)가 인간에게 질병을 일으킬 수 있다는 사실이 보고되었고 1980년 이후 AIDS 환자에게서 M. avium complex가 전신질환을 유발한다고 알려진 다음부터 비결핵마이코박테리아에 대한 관심이 높아지고 있다. 비결핵마이코박테리아에 의한 질환은 임상적인 소견이나 일반적인 병리소견이 결핵과 유사하지만 비결핵마이코박테리아는 생활환경에 널리 분포하고 있어서 임상 가검물로부터 분리되어도 병원성 여부를 판단하기 어려워 진단이 쉽지 않다. 또한 대부분 각종 항결핵제에 약제 내성을 보이고 있어서 치료가 어려우며 재발율도 높은 것으로 알려져 있다. 여러 약제에 내성을 가진 균주가 점차 증가하고 있고 결핵균과 비결핵균은 치료가 달라지므로 이들에 대한 신속하고 정확한 동정방법이 요구되고 있다.In the 1950s, it was reported that Mycobacteria other than tuberculosis (MOTT) can cause disease in humans.Since 1980, the M. avium complex has been known to cause systemic diseases in AIDS patients. Interest is growing. Non-tuberculous mycobacteria can be diagnosed with clinical findings and general pathology similar to tuberculosis, but non-tuberculosis mycobacteria are widely distributed in living environments, making it difficult to determine pathogenicity even when isolated from clinical specimens. In addition, since most of the anti-tuberculosis drugs have shown drug resistance, treatment is difficult and recurrence rate is known to be high. Strains resistant to various drugs are gradually increasing, and since the treatment of Mycobacterium tuberculosis bacteria and non-tuberculosis bacteria is different, there is a need for a rapid and accurate identification method for them.
이러한 결핵발병율과 다제내성 결핵균주의 증가로 결핵의 효과적인 치료 및 관리를 위해 TB complex 뿐만 아니라 MOTT 균주의 보다 신속하고 정확한 결핵균의 동정방법이 요구되고 있다.With the increase in the incidence of tuberculosis and multidrug-resistant tuberculosis strains, there is a need for a faster and more accurate method for identifying TB bacteria as well as TB complexes for effective treatment and management of tuberculosis.
마이코박테리아 감염여부의 조기진단과 결핵균 종류의 확인은 치료에 있어 상당히 중요하므로 여러 가지 진단방법들이 연구되고 개발되어 왔다. 현재 이용되고 있는 동정 및 감염여부 진단방법들과 그 장단점은 아래와 같다.Early diagnosis of mycobacteria and the identification of Mycobacterium tuberculosis bacteria are of great importance for treatment, and various diagnostic methods have been studied and developed. Currently used identification and infection diagnosis methods and their advantages and disadvantages are as follows.
첫째, 미생물학적 방법인 도말 및 배양검사가 있다. 이 방법은 마이코박테리아처럼 세대기간이 길어 배양시간이 오래 걸리고 실험자에게 감염 위험이 많이 수반되는 병원성 미생물인 경우에 적합하지 않다.First, there is a microbiological method, smear and culture test. This method is not suitable for pathogenic microorganisms, such as mycobacteria, which require longer incubation times and higher risk of infection for the experimenter.
둘째, 중합효소 연쇄반응(Polymerase Chain Reaction, PCR) 방법은 민감도와 특이도가 높으며 마이코박테리아처럼 분리 배양에 오랜 시간이 걸리는 병원균의 검출에 매우 유용하다. 특히 소량의 DNA를 증폭시켜 검출하므로 균주의 배양과정을 거치지 않고 검체에 존재하는 소량의 병원균만으로도 동정이 가능하다. 이러한 PCR에 의한 검출은 증폭시키는 표적 DNA에 따라 여러 가지 방법이 소개되고 있는데 그 중에서도 여러 copy로 존재하는 IS6110과 16S rRNA를 주로 사용하고 있다.Second, the polymerase chain reaction (PCR) method has high sensitivity and specificity and is very useful for detecting pathogens that take a long time to separate and culture like mycobacteria. In particular, since a small amount of DNA is amplified and detected, only a small amount of pathogens present in the sample can be identified without going through the culture process of the strain. The detection by PCR has been introduced in various ways depending on the target DNA to be amplified. Among them, IS6110 and 16S rRNA, which exist in several copies, are mainly used.
셋째, 마이코박테리아 균체 성분의 물리화학적 분석방법은 마이코박테리아의 균체 성분중 지방화합물을 gas chromatography와 mass spectrometry를 이용하여 검출하고 있다. 특이도가 높기는 하나 고가의 장비가 필요하다.Third, the physicochemical analysis of mycobacterial cell components detects fatty compounds in mycobacterial cells using gas chromatography and mass spectrometry. Although the specificity is high, expensive equipment is needed.
넷째, 혈청학적 방법에 의한 균체성분의 검출은 균항원에 대한 항체를 흡착시킨 혈구나 latex 입자를 이용한 응집반응과 효소를 항체에 결합시킨 효소결합면역 분석법등이 이용되고 있다. 그러나 이 기법은 매우 정교하여 세심한 주의를 요하므로 한정된 검사실에서만 가능하다.Fourth, the detection of cell components by serological methods includes the aggregation reaction using blood or latex particles which adsorb the antibody to the bacterial antigen, and the enzyme-linked immunoassay method in which the enzyme is bound to the antibody. However, this technique is very sophisticated and requires careful attention and is only possible in limited laboratories.
다섯째, 마이코박테리오파아지 L5에 luciforase 유전자를 삽입해 마이코박테리아에 감염시켜 배지내 첨가된 luciferin으로 발광여부를 보아 검색을 할 수 있는 방법이 있다.(W.R. JACOBS, R.G. BARLETTA, R. UDANI, J. CHAN, G. KALKUT, G. SOSNE, T. KIESER, G.J. SARKIS, G.F. HATFUL, B.R. BLOOM. 1993, Science 260: 819-822)Fifth, there is a method to insert the luciforase gene into mycobacteria L5 and infect it with mycobacteria to search for the luminescence with luciferin added in the medium. (WR JACOBS, RG BARLETTA, R. UDANI, J. CHAN , G. KALKUT, G. SOSNE, T. KIESER, GJ SARKIS, GF HATFUL, BR BLOOM. 1993, Science 260: 819-822)
여섯째, 올리고뉴클레오타이 프로브의 혼성화(hybridization)에 의한 동정방법이 있다.(A. TROESCH, H. NGUYEN, C.G.MIYADA, S. DESVARENNE, T.R. GINGERAS, P.M. KAPLAN, P. CROS and C. MABILAT. J. Clin. Microbiol. 1999, 37: 49-55.)Sixth, there is a method of identification by hybridization of oligonucleotide probes (A. TROESCH, H. NGUYEN, CGMIYADA, S. DESVARENNE, TR GINGERAS, PM KAPLAN, P. CROS and C. MABILAT. J. Clin.Microbiol. 1999, 37: 49-55.)
본 발명은 마이코박테리아균종 중 TB complex의 특이적인 염기서열에 반응하여 TB complex와 MOTT균종을 구별하는데 사용되는 올리고뉴클레오티드 프로브를 제공하며, 올리고뉴클레오티드 프라이머를 사용한 PCR반응에 의하여 TB complex와 MOTT를 구별하는 방법을 제공한다. 본 발명에 의해 마이코박테이아균종 중 TB complex인지 MOTT인지를 판별할수 있다.The present invention provides an oligonucleotide probe used to distinguish between TB complex and MOTT species in response to specific nucleotide sequences of TB complex among mycobacteria strains, and distinguishes TB complex and MOTT by PCR using oligonucleotide primers. Provide a method. According to the present invention, it is possible to determine whether TB complex or MOTT among mycobacterium species.
도 1은 마이코박테리아의 ITS 및 ITS의 PCR 증폭에 이용되는 프라이머의 위치에 관한 개요도, 도 2는 16S와 23S를 일부 포함하는 서열번호 3, 4의 염기서열의 프라이머쌍을 이용하여 마이코박테리아의 ITS를 중합효소연쇄반응(PCR)을 실시한 후 전기영동한 사진, 도 3는 중합효소 연쇄반응으로 얻어진 마이코박테리움 포튜이튬(Mycobacterium fortuitum)과 마이코박테리움 첼로네(Mycobacterium chelonae)의 ITS를 벡터에 클로닝한 후 확인한 전기영동 사진, 도 4는 마이코박테리아의 속특이적인 염기서열인 서열번호 3과 6, 서열번호 4와 5의 프라이머쌍으로 중합효소연쇄반응(PCR)을 시킨 후 전기영동한 사진, 도 5는 각 균종의 종특이적인 염기서열을을 가지고 제작된 특이적인 프라이머로 각 균종의 핵산시료와 중합효소 연쇄반응을 시킨후 전기영동한 사진이다.1 is a schematic diagram of the position of the primers used for the PCR amplification of ITS and ITS of mycobacteria, Figure 2 is a fragment of the mycobacteria using primer pairs of the nucleotide sequence of SEQ ID NO: 3, 4 containing 16S and 23S ITS electrophoresis after polymerase chain reaction (PCR), Figure 3 shows the ITS of Mycobacterium fortuitum and Mycobacterium chelonae obtained by the polymerase chain reaction Electrophoresis photographed after cloning in a vector, FIG. 4 shows electrophoresis after polymerase chain reaction (PCR) with primer pairs of SEQ ID NOs: 3 and 6, and SEQ ID NOs: 4 and 5, which are genospecific sequences of mycobacteria. One picture, Figure 5 is a picture of the electrophoresis after the polymerase chain reaction of the nucleic acid sample of each species with a specific primer prepared with the species-specific nucleotide sequence of each species.
본 발명은 마이코박테리아의 속 공통적인 염기서열 부위와 속 특이적인 염기서열 부위를 프로브나 프라이머로 고안하여 기존의 균 배양 및 생화학적 방법에 의한 균 동정법을 대치할 수 있는 간단하고 정확도가 높은 효율적인 방법을 제공한다. 이를 위하여 동정 프로브와 프라이머는 마이코박테리아의 ITS 염기서열에서 디자인 하였는데 ITS는 흔히 표적 DNA로 사용되는 16S rRNA보다 다형성 지역이 많고 동시에 보존적인 지역이 존재하므로 유전형 감별을 위한 표적 DNA로서 높은 유용성을 갖고 있는 염기서열이다. 본 발명에서는 아직 염기서열이 밝혀지지 않은 M. fortuitum과 M. chelonae의 염기서열을 밝히고 이 두 균주의 염기서열과 공개되어 있는 염기서열 정보를 multialignment와 blast로 분석하여 마이코박테리아를 동정하는 프로브 및 프라이머를 제공한다. 또한 이론적으로 동일한 부위의 다형성(polymorphism)으로 감별이 가능한 부위를 선택하여 균종 특이적인 프로브와 프라이머를 고안한다.The present invention is a simple, high-accuracy and efficient method that can replace the existing bacterial culture and biochemical methods of bacterial identification by devising a common sequence region and genus specific sequence region of mycobacteria as probes or primers. Provide a method. To this end, identification probes and primers were designed from the ITS sequence of mycobacteria. ITS has more polymorphic regions and conservative regions than 16S rRNA, which is commonly used as target DNA, and therefore has high utility as target DNA for genotyping. The base sequence. In the present invention, the nucleotide sequence of M. fortuitum and M. chelonae, which have not yet been identified, are identified and the nucleotide sequence of the two strains and the disclosed nucleotide sequence information are analyzed by multialignment and blast to identify mycobacteria and probes and primers. To provide. In addition, theorem-specific probes and primers are designed by selecting sites that can be differentiated by polymorphism of the same sites.
본 발명을 하기 실시예에 의거하여 보다 구체적으로 설명한다. 그러나 본 발명의 범위이 이들 실시예로 한정되는 것은 아니다.The present invention is explained in more detail based on the following examples. However, the scope of the present invention is not limited to these examples.
실시예 1. 결핵균의 배양 및 genomic DNA분리Example 1 Culture of Mycobacterium Tuberculosis and Genomic DNA Isolation
마이코박테리아를 유전자은행(Korean Collection for Type Culture, KCTC)와 ATCC(American Type Culture Collection)으로부터 표준균주를, 대한결핵협회와 결핵병원을 통해서 임상균주를 확보하였으며 균주의 보관과 배양은 부산대학병원 임상병리과 임상미생물 전공교수의 관리하에 수행하였다. 마이코박테리아 DNA 추출은 다음과 같은 방법으로 실행하였다. 마이코박테리아를 Ogawa 배지에서 배양시킨 후 1백금이를 따서 원심분리용 튜브에 넣고 InstaGene matrix(Bio-Rad Co.)를 200㎕를 가하여 부유시킨 후 56℃에서 30분간 유지하였고 10초 동안 vortex한 후 100℃에서 8분간 열처리한다. 다시 10초간 vortex한 후 12,000rpm에서 3분간 원심분리하여 상층액을 새 튜브로 옮겨 -20℃에 보관하였다. 분리된 DNA 2㎕를 PCR 반응에 사용하였다.The standard strains were obtained from Mycobacteria from Korean Collection for Type Culture (KCTC) and American Type Culture Collection (ATCC), and clinical strains were obtained through the Korean Tuberculosis Association and Tuberculosis Hospital. It was performed under the management of pathology and clinical microbiology professor. Mycobacterial DNA extraction was performed in the following manner. After incubating the mycobacteria in Ogawa medium, 100 μl of this was placed in a centrifuge tube, added with 200 μl of InstaGene matrix (Bio-Rad Co.), suspended for 30 minutes at 56 ° C., and then vortexed for 10 seconds. Heat-process for 8 minutes at 100 degreeC. After vortex again for 10 seconds, the mixture was centrifuged at 12,000 rpm for 3 minutes, and the supernatant was transferred to a new tube and stored at -20 ° C. 2 μl of the isolated DNA was used for the PCR reaction.
실시예 2. 마이코박테리아의 ITS를 증폭시키는 프라이머 제조Example 2. Preparation of Primer to Amplify ITS of Mycobacteria
마이코박테리아에 있어서 ITS부근의 염기서열의 배열은 제 1도와 같다. 따라서 ITS를 증폭시키기 위해서 마이코박테리아의 16S rRNA와 23S rRNA의 보존적인 지역중의 일부 염기서열을 선정하여 프라이머로 제작하였다. 프라이머 디자인은 이미 공개되어 있는 마이코박테리아의 16S와 23S rRNA의 염기서열을 multialignment와 blast search로 컴퓨터 분석하여 선정하였다. 선정된 프라이머는 서열번호 3, 4의 염기서열을 가지며, 이를 사용하여 16S rRNA와 23S rRNA 일부와 함께 ITS부위가 약 500 bp 크기로 선택적으로 증폭되도록 하였다. 위의 프라이머로 증폭시킨 결과는 제2도와 같다. ITS 증폭 프라이머를 포함하여 실험에 사용한 모든 프라이머는 BioBasic(캐나다)에 의뢰하여 Perkin-Elmer DNA synthesizer로 50 nmol 농도로 제작하여 사용하였다.In the mycobacteria, the nucleotide sequence near the ITS is shown in FIG. Therefore, in order to amplify ITS, some nucleotide sequences of conserved regions of 16S rRNA and 23S rRNA of mycobacteria were selected and prepared as primers. The primer design was selected by computer analysis of the nucleotide sequences of 16S and 23S rRNAs of mycobacteria, which have already been published. The selected primers had the nucleotide sequences of SEQ ID NOs: 3 and 4, and were used to selectively amplify the ITS region to about 500 bp with 16S rRNA and a part of 23S rRNA. Amplification with the above primer is shown in FIG. All primers used in the experiment, including the ITS amplification primers, were made at a concentration of 50 nmol by Perkin-Elmer DNA synthesizer by BioBasic (Canada).
실시예 3 PCR 반응 및 산물의 확인Example 3 PCR Reactions and Identification of Products
PCR 반응물의 조성은 다음과 같다. 500 mM KCl, 100 mM Tris HCl(pH 9.0), 1% Triton X-100, 0.2 mM deoxynucleoside triphosphates(dATP, dGTP , dTTP and dCTP) 1.5 mM MgCl2, 1 pmol primer, 1U Taq DNA polymerase(Bio Basic Inc.) 이 혼합액을 94℃에서 5분간 반응시켜 충분히 변성시킨 후 94℃에서 1분, 60℃에서 1분, 72℃에서 1분씩 30회 반응시켰으며, 마지막으로 72℃에서 10분간 연장하였다. 반응이 끝난 후 1.5% 아가로우즈 젤(agarose gel)에 전기영동하여 PCR 산물을 확인하였다. Genbank의 자료를 통해서 미리 예견하였던 바와 같이 16S rRNA와 23S rRNA의 보존적인 프라이머로 증폭시킨 ITS의 크기가 약 500 bp로 나타났으나 마이코박테리움 스메그마티스(M. smegmatis), 마이코박테리움 아그리(M. agri), 마이코박테리움 모리카엔스(M. morikaense)와 마이코박테리움 갈리나룸(M. gallinarum)등은 다른 균주에 비하여 ITS의 크기가 50bp정도 크게 나났다. 따라서 균주의 종류에 따른 ITS의 크기는 270∼350bp 정도임을 알 수 있다.The composition of the PCR reaction is as follows. 500 mM KCl, 100 mM Tris HCl (pH 9.0), 1% Triton X-100, 0.2 mM deoxynucleoside triphosphates (dATP, dGTP, dTTP and dCTP) 1.5 mM MgCl 2 , 1 pmol primer, 1U Taq DNA polymerase (Bio Basic Inc .) The mixed solution was reacted for 5 minutes at 94 ° C., sufficiently denatured, and then reacted 30 times for 1 minute at 94 ° C., 1 minute at 60 ° C., and 1 minute at 72 ° C., and finally extended at 72 ° C. for 10 minutes. After the reaction, the PCR product was confirmed by electrophoresis on 1.5% agarose gel. As predicted from Genbank's data, the size of ITS amplified by conservative primers of 16S and 23S rRNA was about 500 bp, but the mycobacterium smegmatis and mycobacterium M. agri, Mycobacterium moricaens, and Mycobacterium gallinarum (M. gallinarum) were 50 bp larger than other strains. Therefore, it can be seen that the size of the ITS according to the type of strain is about 270 ~ 350bp.
실시예 4. M. fortuitum과 M. chelonae ITS의 클로닝(cloning)Example 4 Cloning of M. fortuitum and M. chelonae ITS
PCR 반응의 확인이 끝난 후 ITS 염기서열이 공개되어 있지 않은 M. fortuitum과 M. chelonae의 ITS의 반응물은 PCR purification kit(QIAGEN)로 정제한 후 cloning에 사용하였다. 정제된 ITS의 PCR 산물은 pGEM-T vector(Promega Co. Madison, WI)에 cloning 하였다. Heat-shock을 이용한 유전형질 도입방법으로 숙주인 E. coli JM 109내로 유도시켜 형질전환체들을 준비한 X-gal/IPTG/Amp+/LB 한천 배지에 도말하여 37℃ 배양기에 16-18시간 배양하였다. 배양 후 흰색의 균락만을 골라내어 LB(Amp+) 액체배지에 키워 플라스미드를 분리, 정제하였다. 플라스미드 DNA는 QIAprep kit로 분리하고 제한효소로 잘라 삽입된 DNA 절편을 확인하였다(제3도).After confirming the PCR reaction, the reactions of ITS of M. fortuitum and M. chelonae, whose ITS sequences were not disclosed, were purified by PCR purification kit (QIAGEN) and used for cloning. PCR products of purified ITS were cloned into pGEM-T vector (Promega Co. Madison, Wis.). The genotyping method using heat-shock was induced into E. coli JM 109, a host, and plated on X-gal / IPTG / Amp + / LB agar medium prepared with transformants and incubated for 16-18 hours in a 37 ° C. incubator. After incubation, only white colonies were picked out and grown in LB (Amp +) liquid medium to separate and purify the plasmid. Plasmid DNA was isolated with a QIAprep kit and cut and inserted into DNA fragments with restriction enzymes (FIG. 3).
실시예 5. DNA 서열분석Example 5. DNA Sequencing
DNA는 200μmol 농도로 정량하여 반응에 사용하였다. DNA auto sequencer(Perkin Elmer, ABI prim 377 sequencer)로 universal primer M13을 사용하여 dye terminator법으로 염기서열을 결정하였다.DNA was quantified at a concentration of 200 μmol and used for the reaction. DNA sequences were determined by dye terminator method using universal primer M13 as a DNA auto sequencer (Perkin Elmer, ABI prim 377 sequencer).
실시예 6. 올리고뉴클레오티드 프라이머의 선정과 합성Example 6 Selection and Synthesis of Oligonucleotide Primers
실시예 5를 통해서 확보된 M. fortuitum과 M. chelonae의 ITS지역의 염기서열과 Genbank로부터 확보된 다른 마이코박테리아 ITS 염기서열을 multialignment와 blast로 분석하여 마이코박테리아의 ITS의 보존적인 염기서열에 해당되는 것은 마이코박테리아 동정 프라이머로, 다형성이 높은 염기서열에 해당하는 것은 균주 특이 프라이머로 선정하여 디자인하였다.The nucleotide sequence of the ITS region of M. fortuitum and M. chelonae obtained through Example 5 and other mycobacterial ITS sequences obtained from Genbank were analyzed by multialignment and blast, corresponding to the conserved sequences of ITS of mycobacteria. It is designed to identify mycobacterial primers, and to designate strain-specific primers that correspond to nucleotide sequences with high polymorphism.
디자인한 프라이머의 ITS내에서 위치 및 그 염기서열은 표 1과 같다.The positions and their nucleotide sequences within the ITS of the designed primers are shown in Table 1.
실시예 7. 마이코박테리아 진단 프라이머에 의한 중합효소 반응결과Example 7 Results of Polymerase Reaction by Mycobacterial Diagnostic Primer
마이코박테리에의 속특이성이 있는 서열번호 3과 6의 염기서열을 가지는 프라이머 쌍과 서열번호 4와 5의 염기서열을 가지는 프라이머 쌍을 제작하여 PCR반응을 시킨 결과 마이코박테리아 균주에 대하여 약 350 bp와 200 bp의 크기로 증폭되었으나, 다른 장내미생물인 Staphylococcus aureus, Enterococcus faecium과 Serratia marcescens은 증폭되지 않은 결과를 나타내어 위의 프로브와 프라이머로 마이코박테리아 진단이 가능함을 알 수 있다. 제4도는 실시예 7에 의한 PCR반응결과를 전기영동한 사진이다..The PCR reaction was performed by preparing a primer pair having the nucleotide sequences of SEQ ID NOs: 3 and 6 and the primer pairs having the nucleotide sequences of SEQ ID NOs: 4 and 5 having specific properties of mycobacteria, and about 350 bp with respect to the mycobacterial strain. And amplified to 200 bp, but other intestinal microorganisms, Staphylococcus aureus, Enterococcus faecium and Serratia marcescens, were not amplified, indicating that mycobacteria could be diagnosed with the above probes and primers. 4 is a photograph showing electrophoresis of the PCR reaction results according to Example 7.
실시예8. TB complex와 MOTT 균주의 진단 프라이머에 의한 중합효소 반응결과Example 8. Results of Polymerase Reaction by Diagnostic Primers of TB Complex and MOTT Strains
본 발명에 따른 올리고뉴클레오타이드 프로브를 프라이머로 제작하여 각 균주를 특이적으로 동정이 가능한지에 대한 실험을 PCR의 증폭여부로 확인하였다.TB complex 동정을 위해서 서열번호 3의 과 10의 염기서열을 선택, MOTT균주중 MAC의 동정을 위해서 서열번호 21과 18의 염기서열을 선택, M. fortuitum의 동정을 위해서는 서열번호 31과 23의 염기서열을 선택, M. chelonae의 동정을 위해서는 서열번호 34와 37의 염기서열을 선택, M. gordonae의 동정을 위해서는 서열번호 40과 42의 염기서열을 선택, M. terra의 동정을 위해서는 서열번호 47과46의 염기서열을 선택, M. scrofulaceum의 동정을 위해서는 서열번호 51과 52의 염기서열을 선택하여 첫번째 염기서열의 센스 스트랜드(sense strand)를 가진 프라이머와 두번째 염기서열의 안티센스 스트랜드(antisense strand)를 가진 프라이머를 제작하여 마이코박테리아의 균종과 중합반응시켜 전기영동한 결과 도 7과 같이 효소중합연쇄반응이 일어났음을 확인할 수 있어, 각각의 프라이머쌍에 의한 PCR반응으로 마이코박테리아의 각 균종이 진단가능함을 알 수 있다.The oligonucleotide probe according to the present invention was prepared as a primer to determine whether each strain can be specifically identified by PCR amplification. For identification of the TB complex, sequences of SEQ ID NO: 3 and 10 were selected, Among the MOTT strains, the nucleotide sequences of SEQ ID NOs: 21 and 18 were selected for the identification of MAC, the nucleotide sequences of SEQ ID NOs: 31 and 23 were selected for the identification of M. fortuitum, and the sequences of SEQ ID NOs. 34 and 37 for the identification of M. chelonae. Select base sequence, select nucleotide sequence of SEQ ID NO: 40 and 42 to identify M. gordonae, select base sequence of SEQ ID NO: 47 and 46 to identify M. terra, and sequence number to identify M. scrofulaceum Primers with the sense strand of the first nucleotide sequence and the primer with the antisense strand of the second nucleotide sequence by selecting the nucleotide sequences of 51 and 52 As a result of the polymerization and electrophoresis of the mycobacterial strain, the polymerase chain reaction was confirmed as shown in FIG. 7, and it was found that each microbial strain of mycobacteria could be diagnosed by PCR with each primer pair. have.
이상과 같이 본 발명에서는 마이코박테리아의 TB complex와 MOTT균종의 구별을 위한 올리고 뉴클레오티드 프로브와 프라이머를 제공하여 결핵균종을 정확하고 쉽게 판단할 수 있는 수단을 제공한다.As described above, the present invention provides an oligonucleotide probe and a primer for distinguishing the TB complex of the mycobacteria and the MOTT strain, thereby providing a means for accurately and easily determining tuberculosis.
Claims (2)
Priority Applications (32)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990019634A KR20000075181A (en) | 1999-05-29 | 1999-05-29 | Method and probe for detection of Mycobacteria species |
CNA2004100063064A CN1542141A (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020017003298A KR100316095B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020017003299A KR100343607B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020017003297A KR100316094B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020017003295A KR100316092B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020017003296A KR100316093B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020017003300A KR100343608B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
CN00808201A CN1353753A (en) | 1999-05-29 | 2000-05-16 | Oligouncleotide for detection and identification of mycobacteria |
JP2001500749A JP2003501023A (en) | 1999-05-29 | 2000-05-16 | Oligonucleotides for identification of mycobacterial species |
CNA2004100063079A CN1542142A (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
PCT/KR2000/000477 WO2000073436A1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
AU46201/00A AU4620100A (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
US09/980,052 US6670130B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of Mycobacteria |
KR1020017003220A KR100343606B1 (en) | 1999-05-29 | 2000-05-16 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071558A KR100343617B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071563A KR100343622B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071557A KR100343616B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071564A KR100343623B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071555A KR100343614B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR20010071559A KR100343618B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071552A KR100343611B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071553A KR100343612B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071551A KR100343610B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071550A KR100343609B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071554A KR100343613B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071556A KR100343615B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071560A KR100343619B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071562A KR100343621B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
KR1020010071561A KR100343620B1 (en) | 1999-05-29 | 2001-11-17 | Oligonucleotide for detection and identification of mycobacteria |
US10/448,914 US20030235856A1 (en) | 1999-05-29 | 2003-05-30 | Oligonucleotide for detection and identification of mycobacteria |
US10/448,836 US20030207313A1 (en) | 1999-05-29 | 2003-05-30 | Oligonucleotide for detection and identification of Mycobacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990019634A KR20000075181A (en) | 1999-05-29 | 1999-05-29 | Method and probe for detection of Mycobacteria species |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20000075181A true KR20000075181A (en) | 2000-12-15 |
Family
ID=19588618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990019634A KR20000075181A (en) | 1999-05-29 | 1999-05-29 | Method and probe for detection of Mycobacteria species |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20000075181A (en) |
-
1999
- 1999-05-29 KR KR1019990019634A patent/KR20000075181A/en active Search and Examination
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2154106C2 (en) | Simultaneous determination, identification and differentiation of eubacterial taxons using hybridization analysis | |
KR100343610B1 (en) | Oligonucleotide for detection and identification of mycobacteria | |
CN101210265A (en) | Method and material for simultaneously detecting mycobacterium tuberculosis compound and identifying its medicament resistance | |
Mijs et al. | Evaluation of a commercial line probe assay for identification of Mycobacterium species from liquid and solid culture | |
US5597911A (en) | Mycobacterial nucleic acid hybridization probes and methods of use | |
KR100446850B1 (en) | A method for identifying Micobacteria tuberculosis and non-tuberculosis Micobacteria, together with detecting resistance to an antituberculsis drug of Micobacteria obtained by mutation of rpoB gene | |
US5518884A (en) | Nucleic acid sequences specific for mycbacterium kansasii | |
US20040110129A1 (en) | Multiplex hybridization system for identification of pathogenic mycobacterium and method of use | |
AU710996B2 (en) | Compositions and methods for the detection of mycobacterium kansasii | |
Lungu et al. | Differentiation of Nocardia from rapidly growing Mycobacterium species by PCR-RFLP analysis | |
Chen et al. | Identification and differentiation of Mycobacterium avium and M. intracellulare by PCR | |
KR20000075178A (en) | sequence of ITS in M. fortuitum | |
KR20000075181A (en) | Method and probe for detection of Mycobacteria species | |
KR20000075180A (en) | Method and Tool for detection of Mycobacteria | |
KR20000075179A (en) | sequence of ITS in M. chelonae | |
KR20000075182A (en) | Method and probe for Genus- and Species-specific detection of Mycobacteria | |
EP0945462B1 (en) | Mycobacterium tuberculosis specific DNA fragment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination |